Clin2
NCT07050745Likely a fitRecruiting

Cervical cancer screening study for women in Kenya

Cervical CancerCervical Cancer ScreeningHPV DNA

Part of Cancer, Women’s health & pregnancy clinical trials.

This study aims to make cervical cancer screening easier and more patient-friendly for women in Kenya. If you are a woman between 25 and 49, not pregnant or recently postpartum, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,980 people
Ages
25 years to 49 years
Study type
Interventional

Who can take part

  • You are a woman between 25 and 49 years old.
  • You are not currently pregnant.
  • It has been more than 6 weeks since you gave birth (if you recently had a baby).
  • You have not already been diagnosed with cervical cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06042543Recruiting
Cervical cancer screening trial for unscreened women

This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.

Cincinnati, Ohio
NCT07593066Not yet recruiting
Cervical cancer screening study for women

This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.

Coyhaique, Aysén
NCT07181278Recruiting
Better cervical cancer screening for women with HIV in Cameroon

This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.

Bafoussam
NCT02956031Recruiting
Cervical screening study for prevention in South African women

This study checks cervical “pre-cancer” and cancer early using cervical screening tests. You may benefit by getting recommended results and next steps, like treatment if something concerning is found.

Pretoria, Gauteng
NCT06536855Not yet recruiting· Phase 4
HPV vaccine and screening study for women in Rwanda

This study tests giving the HPV vaccine along with HPV screening to quickly reduce HPV infection and cervical cancer. It is for women aged 23-29 in Rwanda who choose to join.

NCT05848557Recruiting
Mobile app study for cervical cancer screening and education

This study tests a mobile health tool (an app) and related surveys to improve knowledge and screening awareness for cervical cancer, including HPV risk and acceptability. It involves people working in cervical cancer screening and women in specific communities, with participation based on consent and eligibility for screening.

Kisumu

Hear when a new Cervical Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.